This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Glaxo Group Limited. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Kevin Meng: Innovator in Pharmaceutical Chemistry
Introduction
Kevin Meng is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on oxadiazole derivatives. His research focuses on developing compounds with potential pharmacological applications.
Latest Patents
Kevin Meng holds 1 patent for his invention of 1,2,4-oxadiazole indole compounds. This patent relates to novel oxadiazole derivatives that exhibit pharmacological activity. The invention includes processes for their preparation, pharmaceutical compositions containing these compounds, and their use in treating various disorders.
Career Highlights
Kevin is currently employed at Glaxo Group Limited, where he continues to advance his research in pharmaceutical development. His work is instrumental in creating new therapeutic options for patients.
Collaborations
Some of Kevin's notable coworkers include Qian Liu and Jose Luis Castro Pineiro. Their collaborative efforts contribute to the innovative environment at Glaxo Group Limited.
Conclusion
Kevin Meng is a dedicated inventor whose work in pharmaceutical chemistry is paving the way for new treatments. His contributions to the field are invaluable, and his ongoing research promises to enhance healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile